S2Medical Past Earnings Performance

Past criteria checks 0/6

S2Medical's earnings have been declining at an average annual rate of -6.5%, while the Medical Equipment industry saw earnings growing at 22.9% annually. Revenues have been declining at an average rate of 12.1% per year.

Key information

-6.5%

Earnings growth rate

24.6%

EPS growth rate

Medical Equipment Industry Growth6.2%
Revenue growth rate-12.1%
Return on equity-18.3%
Net Margin-16.9%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How S2Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OM:S2M Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2411-2150
31 Mar 2411-17170
31 Dec 238-23190
30 Sep 237-26240
30 Jun 236-28260
31 Mar 236-28260
31 Dec 226-29320
30 Sep 226-29310
30 Jun 226-26290
31 Mar 229-23270
31 Dec 2111-20260
30 Sep 2115-19240
30 Jun 2115-19240
31 Mar 2129-15240
31 Dec 2028-15230
30 Sep 2024-15240
30 Jun 2025-14230
31 Mar 208-19220
31 Dec 196-18210
30 Sep 197-13190
30 Jun 195-15190
31 Mar 195-12160
31 Dec 184-11150
30 Sep 182-11120
30 Jun 182-790
31 Mar 182-780
31 Dec 172-570
31 Dec 163-140
31 Dec 152010

Quality Earnings: S2M is currently unprofitable.

Growing Profit Margin: S2M is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: S2M is unprofitable, and losses have increased over the past 5 years at a rate of 6.5% per year.

Accelerating Growth: Unable to compare S2M's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: S2M is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (31%).


Return on Equity

High ROE: S2M has a negative Return on Equity (-18.34%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:12
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

S2Medical AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution